Spectranetics Corporation to Participate in Pacific Growth’s Cardiology and Metabolic Diseases Conference on July 12

COLORADO SPRINGS, Colo., July 10 /PRNewswire-FirstCall/ -- Spectranetics Corporation today announced that it will participate in the Pacific Growth Equities Cardiology and Metabolic Diseases Conference on July 12, 2007, at the Grand Hyatt Hotel in New York City.

Spectranetics’ president and chief executive officer John G. Schulte and chief financial officer Guy A. Childs will participate in the format of a series of one-on-one and small group meetings throughout the day.

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy “cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information visit http://www.spectranetics.com.

COMPANY CONTACT: INVESTOR & MEDIA CONTACTS: Spectranetics Corporation Lippert/Heilshorn & Associates, Inc. Guy Childs, Chief Financial Officer Bruce Voss or Don Markley (719) 633-8333 (310) 691-7100 http://www.spectranetics.comhttp://www.lhai.com

Spectranetics Corporation

CONTACT: Guy Childs, Chief Financial Officer of Spectranetics Corporation,+1-719-633-8333; investors and media, Bruce Voss or Don Markley, both ofLippert/Heilshorn & Associates, Inc., +1-310-691-7100, both forSpectranetics Corporation

MORE ON THIS TOPIC